I.R.S.T

Contact person Dr. Dino Amadori,MD, Chief of Institute
Address Via Piero Maroncelli 40
47014 Meldola (FORLI‘)
Country

Italy

Contact Tel: +390543739415 / 12 -
Web I.R.S.T.
Istituto Scientifico Romagnolo per lo Studio e la Cura die Tumori ( I.R.S.T.), Meldola, Italy

History

The Centre was founded in 2007and is situated in Meldola, a small town in Emilia-Romagna. A network of interconnected medical services makes I.R.S.T. a centre of excellence for cancer management and research. Also, in February 2012, it was acknowledged as an approved Centre for Cancer Research (IRCCS) by the Italian Ministry of Health.

Profile

The Institute has Medical Oncology, Nuclear Medicine, Radio-Metabolic and Immunotherapy Departments as well as a Radiotherapy Unit, all characterised by avant-garde technology.

There are 36 beds (10 single rooms) in the Oncology ward and 28 beds in the Day Hospital.

The centre is staffed as follows: ward nurses, Day Hospital nurses, healthcare assistants, ward sisters, physicians, psychologist, health physicists, biologists, technicians, pharmacists, biostatisticians and data-managers. The staff also includes administrative employers for a total amount of about 350 workers.

From an organisational point of view, clinical activities in the Medical Oncology Department are subdivided into Follow-up Clinic, Day Hospital and Inpatient Ward. The centre’s multidisciplinary approach enables a wide range of personalised diagnostic-therapeutic programmes to be offered to patients.

Specialities

Areas of high scientific interest at the Institute include osteo-oncology, locoregional-chemotherapy, Immunotherapy, Radiotherapy, onco-pneumology, onco-dermatology and neuroendocrine tumours.

Palliative and supportive care

The centre is also part of the local Palliative Care Network, which comprises a Home Care Service and two Hospices in nearby towns. Palliative care is provided at the Institute by palliative care experts and continued at the Hospices. Close collaboration between the different professional figures guarantees continuity of care from diagnosis to end-of-life care.